Qube Research & Technologies (QRT)’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16M | Buy |
+3,844
| New | +$1.16M | ﹤0.01% | 1740 |
|
|
2024
Q2 | – | Sell |
-1,158
| Closed | -$309K | – | 3886 |
|
|
2024
Q1 | $309K | Buy |
1,158
+1,125
| +3,409% | +$300K | ﹤0.01% | 2373 |
|
|
2023
Q4 | $7.64K | Buy |
+33
| New | +$7.64K | ﹤0.01% | 3220 |
|
|
2022
Q3 | – | Sell |
-10,327
| Closed | -$739K | – | 2755 |
|
|
2022
Q2 | $739K | Buy |
+10,327
| New | +$739K | 0.01% | 1224 |
|
|
2021
Q3 | – | Sell |
-6,364
| Closed | -$620K | – | 2552 |
|
|
2021
Q2 | $620K | Buy |
6,364
+2,473
| +64% | +$241K | 0.01% | 1163 |
|
|
2021
Q1 | $455K | Buy |
+3,891
| New | +$455K | 0.01% | 1231 |
|
|
2020
Q4 | – | Sell |
-7,093
| Closed | -$842K | – | 2042 |
|
|
2020
Q3 | $842K | Buy |
7,093
+5,243
| +283% | +$622K | 0.01% | 858 |
|
|
2020
Q2 | $210K | Buy |
+1,850
| New | +$210K | ﹤0.01% | 1419 |
|